BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23351040)

  • 21. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites.
    Wang WW; Khetani SR; Krzyzewski S; Duignan DB; Obach RS
    Drug Metab Dispos; 2010 Oct; 38(10):1900-5. PubMed ID: 20595376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologically active metabolites in drug discovery.
    Sun S; Wesolowski SS
    Bioorg Med Chem Lett; 2021 Sep; 48():128255. PubMed ID: 34245850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metabolites of injected chlorogenic acid in rats].
    Xie C; Zhong DF; Chen XY
    Yao Xue Xue Bao; 2011 Jan; 46(1):88-95. PubMed ID: 21465813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.
    Jian W; Xu Y; Edom RW; Weng N
    Bioanalysis; 2011 Apr; 3(8):899-912. PubMed ID: 21510763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of metabolic fingerprinting as a tool for the modernisation of TCM preparations.
    Sheridan H; Krenn L; Jiang R; Sutherland I; Ignatova S; Marmann A; Liang X; Sendker J
    J Ethnopharmacol; 2012 Apr; 140(3):482-91. PubMed ID: 22338647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent highlights of metabolomics for traditional Chinese medicine.
    Zhang A; Sun H; Wang X
    Pharmazie; 2012 Aug; 67(8):667-75. PubMed ID: 22957430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds.
    Liu G; Tian Y; Li G; Xu L; Song R; Zhang Z
    Drug Metab Dispos; 2013 Mar; 41(3):622-33. PubMed ID: 23277344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of metabolites with kernel-partial least squares (K-PLS).
    Embrechts MJ; Ekins S
    Drug Metab Dispos; 2007 Mar; 35(3):325-7. PubMed ID: 17142559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pharmacokinetic process: is the drug getting to its site of action?: Drug metabolism].
    Carrillo Norte JA
    Rev Enferm; 2011; 34(7-8):52-60. PubMed ID: 21919387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic fingerprinting of Tussilago farfara L. using ¹H-NMR spectroscopy and multivariate data analysis.
    Zhi HJ; Qin XM; Sun HF; Zhang LZ; Guo XQ; Li ZY
    Phytochem Anal; 2012; 23(5):492-501. PubMed ID: 22371211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.
    Dalvie D; Obach RS; Kang P; Prakash C; Loi CM; Hurst S; Nedderman A; Goulet L; Smith E; Bu HZ; Smith DA
    Chem Res Toxicol; 2009 Feb; 22(2):357-68. PubMed ID: 19146377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs.
    Perola E
    J Med Chem; 2010 Apr; 53(7):2986-97. PubMed ID: 20235539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo metabolism study of rhubarb decoction in rat using high-performance liquid chromatography with UV photodiode-array and mass-spectrometric detection: a strategy for systematic analysis of metabolites from traditional Chinese medicines in biological samples.
    Song R; Xu L; Xu F; Li Z; Dong H; Tian Y; Zhang Z
    J Chromatogr A; 2010 Nov; 1217(45):7144-52. PubMed ID: 20889158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers.
    Liotta E; Gottardo R; Bertaso A; Polettini A
    J Mass Spectrom; 2010 Mar; 45(3):261-71. PubMed ID: 20014151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of reactive metabolites in natural products-driven drug discovery.
    Njuguna NM; Masimirembwa C; Chibale K
    J Nat Prod; 2012 Mar; 75(3):507-13. PubMed ID: 22296642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do Fukui function maxima relate to sites of metabolism? A critical case study.
    Beck ME
    J Chem Inf Model; 2005; 45(2):273-82. PubMed ID: 15807488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma.
    Teichert J; Sohr R; Baumann F; Hennig L; Merkle K; Caca K; Preiss R
    Drug Metab Dispos; 2005 Jul; 33(7):984-92. PubMed ID: 15845750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward understanding the molecular basis for chemical allosteric modulator design.
    Wang Q; Zheng M; Huang Z; Liu X; Zhou H; Chen Y; Shi T; Zhang J
    J Mol Graph Model; 2012 Sep; 38():324-33. PubMed ID: 23085171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.